Today: 12 May 2026
Helport AI Stock Jumps Nearly 50% Premarket as HPAI Draws Fresh Trader Interest

Helport AI Stock Jumps Nearly 50% Premarket as HPAI Draws Fresh Trader Interest

SINGAPORE, May 11, 2026, 19:01 SGT

Helport AI Limited shares surged in U.S. premarket action Monday, giving a lift to the battered Nasdaq-listed AI customer-service play ahead of the bell. HPAI was quoted at $1.47 as of 7:00 a.m. EDT, marking a 49.1% gain from Friday’s $0.9861 close, according to StockAnalysis data.

This shift landed without any new operational disclosure from the company. Helport’s investor-relations site still shows its most recent 2026 updates as the QuickCEP partnership from April 9 and the April 7 AI collections rollout—nothing posted Monday.

So far, the surge has the hallmarks of a liquidity-driven AI chase, not a straightforward reaction to fresh fundamentals. Robinhood’s quote page pegged volume at 6.98 million shares, well above the 742,500 average. TradingView put the float at 7.88 million shares—tight enough that heavy order flow can send prices moving in a hurry.

Singapore-based Helport, listed as HPAI on Nasdaq, offers software-as-a-service to contact-center operators. Its products range from AI-powered real-time support for customer-facing teams to tools for business process outsourcing—essentially, outsourced service tasks.

Shares struggled ahead of Monday’s premarket jump. According to TradingView, HPAI dropped 29.6% in five days, slid 40.6% for the month, and has lost 81.9% over the past year. The stock’s record low came in at 92.5 cents on May 8.

The QuickCEP deal stands out as the next key catalyst for the company. On April 9, Helport outlined plans for the two companies to roll out a fully managed AI agent product targeting global brands and e-commerce operators. Early-stage revenue is penciled in for the second quarter of 2026, with both sides eyeing roughly 50 enterprise clients landing through this partnership over the coming six months.

Chief Executive Guanghai Li didn’t see the agreement as just another software transaction. “We are not selling software,” Li said. “We are selling industrial-grade AI labor capacity.” For QuickCEP, co-founder Nick Peng described the tie-up as a chance to deliver an “out-of-the-box” AI agent to global brands. Helport AI, Inc.

Helport isn’t big by the numbers. For fiscal 2025, revenue climbed 17.9% to $34.9 million, but net income plunged 74.8% to $1.9 million, squeezed by higher R&D, global expansion, and public listing expenses. Cost of revenue grew even faster than sales, shrinking gross margin to 54.87% from the previous 62.81%.

The field is crowded. Five9 is in with its cloud contact-center and AI tools. NiCE touts CXone, pushing the blend of human and AI agents on its experience platform. Genesys? It’s selling an enterprise AI setup to coordinate human and machine teams. Helport, though, keeps it tighter—focusing on contact-center staffing and customer communication linked to tracked outcomes.

Still, the rally could prove fragile. Premarket pops sometimes evaporate when the bell rings, particularly with small-cap names that don’t trade heavily. Helport’s statements in April about its partnership and collections? Those are projections—the firm itself cautioned that real outcomes might not match what’s expected.

Monday night in Singapore, and the focus stayed on stocks: a big bounce for a beaten-down AI player, thin shares in circulation, and traders hunting for evidence that Helport’s AI labor model will convert pilots and partnerships into real, recurring revenue—not just fuel another choppy day of trading.

Stock Market Today

  • QuantumScape Shares Rise 11.7% on Eagle Line Launch and Initial Billings
    May 12, 2026, 5:46 PM EDT. QuantumScape (QS) gained 11.7% following the launch of its Eagle Line pilot-scale solid-state battery cell facility and initial $11 million in customer billings from ecosystem partners. The company reported a narrower GAAP net loss in Q1 2026, driven by reduced operating expenses. This marks a shift toward early commercialization and a potential licensing and royalty revenue stream, altering QuantumScape's risk profile and business model. Investors remain cautious as success depends on partner uptake and scaling production. Analysts' revenue forecasts vary widely, reflecting uncertainty around the new manufacturing blueprint. QuantumScape projects $544.5 million revenue and $33.3 million earnings by 2029, but some estimates are much lower, highlighting diverging market views.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Soluna Holdings Stock in Focus After SEC Clears Share Resale Plan
Previous Story

Soluna Holdings Stock in Focus After SEC Clears Share Resale Plan

Oklo Stock Faces Its Next Big Test as Q1 Earnings Follow Fast NRC Win
Next Story

Oklo Stock Faces Its Next Big Test as Q1 Earnings Follow Fast NRC Win

Go toTop